Capital Impact Advisors »

Kymera Therapeutics shares owned by Capital Impact Advisors

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Capital Impact Advisors from 13F filings

Historical chart of Capital Impact Advisors investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Capital Impact Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Capital Impact Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $960k 24k 40.20
2023-12-31 $608k 24k 25.46